Apr 3 |
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
|
Apr 2 |
VBI Vaccines expands collaboration with Canadian government
|
Apr 2 |
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
|
Feb 14 |
Strategic Licensing Agreements: Brii Bio’s Expansion into Chronic Disease Treatments with VBI Vaccines
|
Feb 14 |
VBI signs deal to sell manufacturing capabilities, certain assets with Brii Biosciences
|
Feb 14 |
Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
|
Feb 14 |
VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
|